First world conference on luteinizing hormone in ART: Landing in Asia Pacific

Reproductive medicine

Fertility

Regional conference by Excemed

Saturday, Nov 19 - Sunday, Nov 20 2016

Bangkok, Thailand

Accreditation

EACCME®

Language

English

Registration status

Closed

To register for this event, contact

Meridiano Congress International (Italy)
Project Manager: Giorgia Di Egidio
T +39 06 88 595 232 - F +39 06 88595 234
giorgia.diegidio@meridiano.it

Registration fee

230.00€

The registration fee is 230€ and includes:
•   Scientific sessions
•   Coffee breaks and luncheons
•   Dinner on November 19, 2016
•   Educational materials
•   Certificate of attendance

Target audiences

This programme is intended for clinicians

embryologists

biologists and scientists working in ART.

Files

Final Programme and Abstract Book

Introduction

Access resources by clicking the Outcomes tab or by scrolling down to the Scientific Programme.

Overview

This conference will review and further enlighten the main topics discussed during the First world conference on luteinizing hormone (LH) in ART: A flight of discovery in Naples, Italy on 27-28 May 2016. The role of LH during folliculogenesis has heightened curiosity for at least three decades. In particular, the scientific community is still divided over recognizing the relevance of LH containing drugs during controlled ovarian stimulation (COS). Availability of recombinant drugs has offered, for the first time, the opportunity to explore the role of the follicle stimulating hormone (FSH) and LH separately. Despite the opportunity, the role of recombinant LH is still a matter of debate. This conference will show evidence from basic science to clinical practice regarding the use of recombinant LH and will illustrate its possible benefits as well as its physiopathological mechanism. Guided by an expert, participants will grasp the rationale for using recombinant LH in assisted reproductive technology as well as understand the role of LH in human reproduction.

Learning objectives

Understand the physiology of LH and its role in ovulation induction
Grasp the state of the art regarding the use of recombinant LH
Individualise groups of patients that required LH during stimulation protocols
Identify specific ovarian reserve markers and genotype polymorphisms useful for tailoring treatments and choosing the best approach

Accreditation details

EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ® ) to provide the following CME activity for medical specialists. The EACCME ® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net

The CME workshop “First world conference on luteinizing hormone in ART: Landing in Asia Pacific” held on 19-20 November 2016 in Bangkok, Thailand, is designated for a maximum of 6 (six) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.

Scientific programme

Saturday, 19 November 2016

From 12.00 Registration

Welcome lunch

14.00 Opening and introduction, R. Fischer (Germany)

Session I: A long runway: Impaired outcome in IVF

14.10 L1 The history of POR: it is time to turn the page? Video lecture, S. C. Esteves (Brazil)

14.35 L2 Ovarian reserve, euploidy rates and ovarian sensitivity: three actors for one movie Video lecture, C. Alviggi (Italy)

15.00 L3 From POR to low prognosis concept: a new proposed stratification by POSEIDON Working Group Video lecture, P. Humaidan (Denmark)

15.25 Coffee break

15.45 Case studies

16.15 Panel discussion

17.00 End of the first day

Sunday, 20 November 2016

08.30 Wrap up

Session II The in-flight movies: "Is too much better than not enough?"

08.45 L4 How many oocytes are needed for one euploid embryo? Video lecture, S. C. Esteves (Brazil)

09.10 L5 COS strategies to increase oocyte number/quality Video lecture, P. Humaidan (Denmark)

09.35 L6 DuoStim: the alternative of oocytes/embryos accumulation programs, C. Alviggi (Italy)

10.00 Case studies

10.30 Panel discussion

11.00 Coffee break

Session III: Landing in the real LH world

11.15 L7 The rationale for the use of LH during COS: from basic science to clinical practice Video lecture, S. C. Esteves (Brazil)

11.40 L8 Which POSEIDON groups may benefit of LH supplementation? Video lecture, C. Alviggi (Italy)

12.05 L9 What about personalized luteal phase support? Video lecture, P. Humaidan (Denmark)

12.30 Case studies

13.00 Panel discussion

13.30 Concluding remarks

13.45 End of the conference

Closing lunch

CME provider

EXCEMED - Excellence in Medical Education

Senior Programme Manager: Chloé Xilinas
T +39 06 420413 505 - F +39 06 420413 677
chloe.xilinas@excemed.org
Medical Advisor: Alessandro Conforti
confale@hotmail.it